You just read:

Agendia Announces New Research Reinforcing MammaPrint® and BluePrint® Testing to Guide Breast Cancer Treatment Management Decisions Across Different Patient Populations and Ages at the 2018 San Antonio Breast Cancer Symposium

News provided by

Agendia, Inc.

Nov 28, 2018, 10:00 ET